section name header

Pronunciation ⬇

KET-a-meen

Classifications ⬆ ⬇

Therapeutic Classification: general anesthetics

Indications ⬆ ⬇

High Alert


Unlabeled Use:
  • Provides sedation, analgesia, and anxiolytic effects.

Action ⬆ ⬇

  • Blocks afferent impulses of pain perception.
  • Suppresses spinal cord activity.
  • Affects CNS transmitter systems.
Therapeutic effects:

Pharmacokinetics ⬆ ⬇

Absorption: Rapidly absorbed after IM administration. IV administration results in complete bioavailability.

Distribution: Rapidly distributed. Enters the CNS.

Metabolism/Excretion: Mostly metabolized by the liver. Some conversion to another active compound.

Half-Life: 2.5 hr.

Time/Action Profile ⬆ ⬇

(anesthesia)

ROUTEONSETPEAKDURATION
IV30 secunknown5–10 min
IM3–4 minunknown12–25 min

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: hypertension, tachycardia, arrhythmias, bradycardia, hypotension

Derm: erythema, rash

EENT: ↑intraocular pressure, diplopia, nystagmus

GI: excessive salivation, hepatotoxicity, nausea, vomiting

GU: cystitis

Local: pain at injection site

MS: ↑skeletal muscle tone

Neuro: emergence reactions, ↑intracranial pressure

Resp: laryngospasm, respiratory depression and apnea (rapid IV administration of large doses)

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

General Anesthesia

Sedation/Analgesia (Unlabeled)

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Toxicity and Overdose:

Implementation ⬆ ⬇

IV Administration:

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Ketalar

Code ⬆

NDC Code